Alyssa H. Zhu

Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial

Ari Green, Jeffrey M. Gelfand, Bruce Cree et al. · The Lancet · 2017 · 548 citations · Full text

Crossover Trial, Neurological Disorder, Neurological Progress +9

Long‐term evolution of multiple sclerosis disability in the treatment era

Bruce Cree, Pierre‐Antoine Gourraud, Carolyn Bevan et al. · Annals of Neurology · 2016 · 430 citations · Full text

Silent progression in disease activity–free relapsing multiple sclerosis

Bruce Cree, Jill A. Hollenbach, Riley Bove et al. · Annals of Neurology · 2019 · 429 citations · Full text

White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group

Laura S. van Velzen, Sinéad Kelly, Dmitry Isaev et al. · Molecular Psychiatry · 2019 · 360 citations · Full text

White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study

Sean N. Hatton, Khoa H Huynh, Leonardo Bonilha et al. · Brain · 2020 · 219 citations · Full text

Neurological Disorder, Corticobasal Degeneration, White Matter +19